Login to Your Account

Government Gets in the Game

Biotech Taps High Tech for Ideas from Start-Up to Finish

By Trista Morrison

Monday, May 14, 2012

Biotech firms have long borrowed ideas from the high tech world. The venture-backed start-up business model on which the entire biotech industry is based came from high tech, and it has served both industries well despite their very different timelines and cost structures. Even so, current capital constraints have put "unprecedented strain" on biotech business models, according to Ernst & Young's Lead Analyst Gautam Jaggi, requiring a rethink of everything from company founding to drug development to healthcare delivery.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription